EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

2‐Arachidonoylglycerol ‐mediated endocannabinoid signaling modulates mechanical hypersensitivity associated with alcohol withdrawal in mice

Amanda Morgan, Danielle Adank, Keenan Johnson, Emily Butler, Sachin Patel iD

Alcoholism: Clinical and Experimental Research · 2022-11 · 46 (11) · 2010-2024

DOI: 10.1111/acer.14949 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alcoholism: Clinical and Experimental Research, online erschienen am 12.10.2022. Verfasst von Amanda Morgan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Behavioral Sciences, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Alcoholism, Substance Withdrawal Syndrome. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAAA NIH HHS, National Institute on Alcohol Abuse and Alcoholism.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Alcohol use disorder (AUD) commonly occurs in patients with chronic pain, and a major barrier to achieving abstinence and preventing relapse is the emergence of hyperalgesia during alcohol withdrawal. Elucidating novel therapeutic approaches to target hyperalgesia associated with alcohol withdrawal could have important implications for treating AUD. Here, we examined the role of 2‐arachidonoylglycerol (2‐AG)‐mediated endocannabinoid (eCB) signaling in the regulation of hyperalgesia associated with alcohol withdrawal in mice. We tested the hypothesis that pharmacological augmentation of 2‐AG signaling could reduce hyperalgesia during withdrawal.

Methods

Male and female C57BL/6J mice were tested during withdrawal from a continuous access two‐bottle choice (2BC) paradigm to investigate how eCB signaling modulates mechanical and thermal sensitivity during withdrawal. Mice were pretreated with the monoacylglycerol lipase (MAGL) inhibitor JZL184 to elevate levels of 2‐AG. Rimonabant or AM630 were given to block CB 1 and CB 2 receptor activity, respectively. DO34 was given to reduce 2‐AG by inhibiting the 2‐AG synthetic enzyme diacylglycerol lipase (DAGL).

Results

After 72 h of withdrawal, male and female mice exhibited increased mechanical, but not thermal, hypersensitivity, which normalized by 7 days. This effect was reversed by pretreatment with JZL184. The effects of JZL184 were prevented by coadministration of either the CB 1 or the CB 2 antagonist. DO34, Rimonabant, and AM630 exacerbated mechanical hypersensitivity during alcohol withdrawal, causing an earlier onset and persistent hypersensitivity even 1 week into withdrawal.

Conclusions

Our findings demonstrate the critical role of 2‐AG signaling in the bidirectional regulation of mechanical sensitivity during alcohol withdrawal, with enhancement of 2‐AG levels reducing sensitivity, and inhibition of 2‐AG signaling exacerbating sensitivity. These data suggest that 2‐AG augmentation represents a novel approach to the treatment of alcohol withdrawal‐associated hyperalgesia and AUD in patients with comorbid pain disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlcoholismSubstance Withdrawal SyndromeMaleFemaleAnimalsMiceEndocannabinoidsRimonabantHyperalgesiaMice, Inbred C57BLReceptor, Cannabinoid, CB1Receptor, Cannabinoid, CB2Arachidonic AcidsGlycerides

Stichwörter der Autor:innen

CB1CB2addictionanalgesiacannabinoidpain

Substanzen

EndocannabinoidsRimonabantReceptor, Cannabinoid, CB1Receptor, Cannabinoid, CB2glyceryl 2-arachidonateArachidonic AcidsGlycerides

Autor:innen und Institutionen

  • Department of Psychiatry and Behavioral Sciences, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Vanderbilt Brain Institute, Vanderbilt University, Nashville, Tennessee, USA.
  • Interdisciplinary Program in Neuroscience, Vanderbilt University, Nashville, Tennessee, USA.

ORCID-Profile: Sachin Patel

Förderung

  • NIAAA NIH HHS
  • National Institute on Alcohol Abuse and Alcoholism

Zitieren

APA

Morgan, A., Adank, D., Johnson, K., Butler, E., & Patel, S. (2022). 2‐Arachidonoylglycerol ‐mediated endocannabinoid signaling modulates mechanical hypersensitivity associated with alcohol withdrawal in mice. Alcoholism: Clinical and Experimental Research, 46(11), 2010-2024. https://doi.org/10.1111/acer.14949

Vancouver

Morgan A, Adank D, Johnson K, Butler E, Patel S. 2‐Arachidonoylglycerol ‐mediated endocannabinoid signaling modulates mechanical hypersensitivity associated with alcohol withdrawal in mice. Alcoholism: Clinical and Experimental Research. 2022;46(11):2010-2024. doi:10.1111/acer.14949

BibTeX
@article{Morgan2022,
  author = {Morgan, Amanda and Adank, Danielle and Johnson, Keenan and Butler, Emily and Patel, Sachin},
  title = {2‐Arachidonoylglycerol ‐mediated endocannabinoid signaling modulates mechanical hypersensitivity associated with alcohol withdrawal in mice},
  journal = {Alcoholism: Clinical and Experimental Research},
  year = {2022},
  volume = {46},
  number = {11},
  pages = {2010--2024},
  doi = {10.1111/acer.14949}
}
Kostenlos starten →